Cargando…

Biomarker testing of cytology specimens in personalized medicine for lung cancer patients

Every patient with advanced non–small cell lung cancer (NSCLC) should be tested for targetable driver mutations and gene arrangements that may open avenues for targeted therapy. As most patients with NSCLC in the advanced stage of the disease are not candidates for surgery, these tests have to be pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyojin, Chung, Jin-Haeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682222/ https://www.ncbi.nlm.nih.gov/pubmed/36345618 http://dx.doi.org/10.4132/jptm.2022.10.17

Ejemplares similares

PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
por: Kim, Hyojin, et al.
Publicado: (2019)

Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer
por: Roy-Chowdhuri, Sinchita
Publicado: (2020)

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
por: Caputo, Alessandro, et al.
Publicado: (2021)

Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine
por: Morii, Eiichi, et al.
Publicado: (2023)

Correction of acknowledgments: PD-L1 testing in non-small cell lung cancer: past, present, and future
por: Kim, Hyojin, et al.
Publicado: (2020)

Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
por: Ahn, Hyein, et al.
Publicado: (2018)

A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
por: Morikawa, Kei, et al.
Publicado: (2022)

Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
por: Kim, Hyojin, et al.
Publicado: (2022)

Role of FNAC, fluid specimens, and cell blocks for cytological diagnosis of lung cancer in the present era
por: Gupta, Nalini, et al.
Publicado: (2015)

Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial
por: Fujita, Kazutaka, et al.
Publicado: (2023)

The Surgical Specimen Is the Personalized Part of Personalized Cancer Medicine
por: Compton, Carolyn C.
Publicado: (2009)

Hypermethylated CDO1 and ZNF454 in Cytological Specimens as Screening Biomarkers for Endometrial Cancer
por: Wang, Lei, et al.
Publicado: (2022)

Molecular Testing of Lung Cancers
por: Shim, Hyo Sup, et al.
Publicado: (2017)

Improvization of conventional cytology by centrifuged liquid-based cytology in oral exfoliative cytology specimen
por: Nambiar, Shwetha, et al.
Publicado: (2016)

Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer
por: Furuya, Naoki, et al.
Publicado: (2020)

Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group
por: Kim, Hyojin, et al.
Publicado: (2014)

Challenges in Cytology Specimens With Hürthle Cells
por: Thodou, Eleni, et al.
Publicado: (2021)

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients
por: Syahruddin, Elisna, et al.
Publicado: (2018)

Usefulness of on‐site cytology of liver tumor biopsy in specimen sampling for cancer genomic profiling test
por: Nakabori, Tasuku, et al.
Publicado: (2023)

The Diagnostic Dilemma of Urothelial Tissue Fragments in Urinary Tract Cytology Specimens
por: Allison, Derek B., et al.
Publicado: (2022)

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC
por: Wang, Hangjun, et al.
Publicado: (2018)

The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
por: Roh, Michael H.
Publicado: (2015)

The usefulness of liquid-based cytology of bronchoalveolar lavage fluid combined with bronchial brush specimens in lung cancer diagnosis
por: Ma, Shanni, et al.
Publicado: (2022)

Colorectal Cancer Biomarkers in the Era of Personalized Medicine
por: Patel, Jai N., et al.
Publicado: (2019)

The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma
por: Heriyanto, Didik S., et al.
Publicado: (2020)

Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing
por: Lee, Jeonghyo, et al.
Publicado: (2022)

Subtyping of non-small cell lung cancer by cytology specimens: A proposal for resource-poor hospitals
por: Celik, Betul, et al.
Publicado: (2019)

Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry
por: Yoshida, Masami, et al.
Publicado: (2017)

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer
por: Chiang, Chi-Lu, et al.
Publicado: (2022)

Cytology Specimen Management, Triage and Standardized Reporting of Fine Needle Aspiration Biopsies of the Pancreas
por: Yoon, Won Jae, et al.
Publicado: (2015)

PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
por: Kim, Hyojin, et al.
Publicado: (2017)

A noninterventional, multinational study to assess PD‐L1 expression in cytological and histological lung cancer specimens
por: Bubendorf, Lukas, et al.
Publicado: (2020)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

γH2AX expression in cytological specimens as a biomarker of response to radiotherapy in solid malignancies
por: Shah, Ketan, et al.
Publicado: (2015)

Non-Small Cell Carcinoma-Not Otherwise Specified on Cytology Specimens in Patients with Solitary Pulmonary Lesion: Primary Lung Cancer or Metastatic Cancer?
por: Lee, Hyoun Wook, et al.
Publicado: (2021)

Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer
por: XU, XIANHUA, et al.
Publicado: (2015)

Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer
por: Mansour, Mohammed S. I., et al.
Publicado: (2021)

Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer
por: Kim, Hyojin, et al.
Publicado: (2018)

Chemotherapy for Lung Cancer in the Era of Personalized Medicine
por: Lee, Seung Hyeun
Publicado: (2019)

Clinical and molecular impacts of tumor mutational burden in histological and cytological specimens from cancer patients
por: Li, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uughgglm0m8bcf8cshm7tlcbe4